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Background: This study will explore the validity of psychiatric diagnoses in administrative registers with special
emphasis on comorbid anxiety and substance use disorders.
Methods: All new patients admitted to psychiatric hospital in northern Norway during one year were asked to
participate. Of 477 patients found eligible, 272 gave their informed consent. 250 patients (52%) with hospital
diagnoses comprised the study sample. Expert diagnoses were given on the basis of a structured diagnostic
interview (M.I.N.I.PLUS) together with retrospective checking of the records. The hospital diagnoses were blind to the
expert. The agreement between the expert’s and the clinicians’ diagnoses was estimated using Cohen’s kappa statistics.
Results: The expert gave a mean of 3.4 diagnoses per patient, the clinicians gave 1.4. The agreement ranged from
poor to good (schizophrenia). For anxiety disorders (F40-41) the agreement is poor (kappa = 0.12). While the expert
gave an anxiety disorder diagnosis to 122 patients, the clinicians only gave it to 17. The agreement is fair concerning
substance use disorders (F10-19) (kappa = 0.27). Only two out of 76 patients with concurrent anxiety and substance
use disorders were identified by the clinicians.
Conclusions: The validity of administrative registers in psychiatry seems dubious for research purposes and even for
administrative and clinical purposes. The diagnostic process in the clinic should be more structured and treatment
guidelines should include comorbidity.
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Psychiatric comorbidity is a prevalent phenomenon and
remains a challenge for the effective delivery of mental
health services. Recent community surveys show that
among those with a psychiatric disorder the lifetime
prevalence of more than one diagnosis is about 50% [1].
The highest rates of comorbidity are observed between
anxiety and affective disorders [1], and affective, anxiety
and substance use disorder often occur together [2,3].
The presence of comorbid disorders is associated with a
significantly higher rate of help seeking [4-6].
To what extent psychiatric case registers or adminis-
trative registers reflect this comorbidity is not known.
Since the 1960s, psychiatric case registers have been
regarded as important epidemiological research tools for
estimating treated incidence, prevalence and patterns of* Correspondence: terje.oiesvold@nlsh.no
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reproduction in any medium, provided the orcare [7]. With the development of new and better infor-
mation and communication technologies, their import-
ance is expected to increase [8,9]. Much of the utility of
a psychiatric case register, however, will depend on the
validity of the psychiatric diagnoses [10]. Byrne et al.
[11] in their review conclude that relatively little high-
quality work exists into systematically measuring the diag-
nostic data validity of registers for research purposes. Al-
most no studies (1 out of 14) performed anything else
than case note reviews to assess validity. Only two of the
studies reviewed stated that the register diagnoses were
blinded to the researchers and inter-rater reliability testing
was only performed in three of the studies.
Thus, there is a need for studies using more stringent
methodological approaches to estimate the validity of
case register diagnoses. In our study a structured diag-
nostic interview was performed on all new patients con-
secutively admitted to psychiatric hospital, comparing
these diagnoses with those given by the clinicians. In aal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of bipolar disorder [12]. In this paper we will present the




The North-Norwegian study on first-time admitted
patients to psychiatric hospital (FINN-study) is a pro-
spective cohort study on treated incidence, utilization,
and outcome in a one-year period and a 12-month fol-
low-up period. The University Hospital in Northern
Norway in Tromsø, and Nordland Hospital in Bodø, par-
ticipated. All admissions to psychiatric hospitals in a
region with a population of about 500 000 people are
administered by these two hospitals. There are 14 com-
munity mental health centres in the region. The psychi-
atric services in Northern Norway are fully described
elsewhere [13].
Included in the study were patients between 18 and 65
years of age who had no previous admissions to the par-
ticipating hospitals and who gave written informed con-
sent to participate. Exclusion criteria were: Lack of
language competency and cognitive impairment such as
dementia, serious mental retardation or other mental
incapacities preventing the individual from giving an
informed written consent. Further, The Regional Ethics
Committee for Medical Research required that a patient
be given at least 24 hrs after admission to consider par-
ticipation, and hence patients who were discharged less
than 3 days after admission had to be excluded. Thus
comprehensive in/out interviews were unfeasible for
short-stay patients. Of 674 first-time admitted patients,
477 patients were found eligible for participation. 272
patients gave their informed consent, and of these 250
patients (52%) with hospital diagnoses comprised the
study sample.
Data collection
Diagnoses were assessed by means of the Mini Inter-
national Neuropsychiatric Interview PLUS (M.I.N.I.PLUS)
[14] Norwegian version 5.0.0. [15]. M.I.N.I. was developed
in Europe and USA as a short diagnostic instrument
for generating DSM-IV criteria diagnoses convertible
to ICD.10 diagnoses [16]. The M.I.N.I.PLUS is an
extended version of the M.I.N.I. that includes information
on specific phobias and has an expanded psychosis mo-
dule. The M.I.N.I.PLUS is built up of 15 modules corre-
sponding to diagnostic categories and collects information
along 23 axis-I problem areas in relation to past and
current symptoms. The interviews were carried out by
psychiatric nurses, psychologists, graduate students in
psychology, a resident doctor and a psychiatrist. Except
for the two students, all had extensive clinical experienceand none had therapeutic or other relations to the
patients. The interviewers underwent systematic training
and consecutive reliability checks using videotaped inter-
views. The interview was performed as soon as possible
after admission when the patient was found eligible to
participate in an interview and had given written consent.
An experienced psychologist (I. Skre), who has studied
the validity and reliability of psychiatric diagnoses during
two decades [17,18], will in the following will be referred
to as the expert. She was not employed at the participa-
ting hospitals and she determined the diagnoses on the
basis of the M.I.N.I. PLUS interviews and retrospective
inspection of the patients’ records. The expert was blind
to the hospital diagnoses. First, the M.I.N.I.PLUS schedule,
including notes made by the interviewer, was reviewed
and scored according to the ICD-10 criteria as they appear
in ICD-10 Diagnostic Criteria for Research [19]. In cases
where the information given in the interview was meagre,
lacking or contradictory, additional information about the
patient was sought from the hospital records: (1) the refer-
ral letter applying for admission, which accompanies all
admissions to psychiatric hospitals in Norway, (2) the
notes written by the receiving medical doctor at the hos-
pital, and (3) when involving an involuntary admission,
the notes written by the specialist in psychiatry/psych-
ology who did the formal evaluation. In order to keep the
expert blind to the hospital diagnoses and the referring
physician’s tentative diagnosis, the information was
extracted from the patient’s file and read aloud to the
expert by an assistant. The assistant was instructed to
omit all material concerning diagnostic evaluations. The
following information was extracted from these docu-
ments: (1) the symptoms and behaviour of the patient in
the days and hours immediately prior to hospitalization,
(2) the symptoms and behaviours observed and described
by the receiving medical doctor and/ or the specialist in
psychiatry/psychology at the hospital. In some cases, when
suspecting an organic mental disorder, any documentation
of results from brain imaging and neuropsychological tests
were used.
In accordance with the ICD-10, a diagnostic hierarchy
was employed only when exclusion criteria were expli-
citly given in the diagnostic manual. When assigning
more than one diagnosis, the diagnoses were listed in
the following order: The first or primary diagnosis was
always the disorder from which the behaviours or symp-
toms stemmed which had resulted in hospitalisation.
Following the main diagnosis were additional disorders
diagnosed in the patient, most often anxiety or somato-
form disorders. Finally, diagnoses for harmful use of or
dependence on psychoactive substances were assigned.
Hospital clinicians are obliged to use the ICD-10 cri-
teria and to make a diagnostic evaluation in the dis-
charge letter which is routinely sent to the patient’s GP.
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and observations made during the hospital stay. Inter-
views with relatives may be used as well as rating scales
and structured interviews, but this is uncommon. The
clinician’s diagnoses are given in the discharge letter
from the hospital. Usually, what is considered the main
disorder causing hospitalization is entered first, as the
primary diagnosis, and additional diagnoses, if assigned,
are entered subsequently. The discharge letter is the
hospital’s summary of diagnostic evaluations, symptoms
and behaviours which have been the focus for treatment,
and which the hospital finds it important to communi-
cate to the patient’s GP, or other primary or secondary
case manager. Thus any clinical significant symptoms
observed and addressed during hospital stay should be
mentioned at discharge.
The Regional Ethics Committee of Northern Norway
approved the study.
Statistics
Descriptive statistics were used to present sample char-
acteristics and the frequencies of the different diagnoses
given by the clinicians as well as by the expert. Kruskall-
Wallis and chi-square statistics were used to assess pos-
sible bias in the study sample. Cohen’s kappa (к) was
used to estimate degree of agreement between expert
and clinical diagnoses. According to the guidelines of
Landis and Koch [20], a kappa agreement < .20 is poor,
.21 - .40 is fair, .41 - .60 is moderate, .61-.80 is good




The study sample was comprised of 250 patients. As can
be seen from Table 1 the mean age was 40.4 years, 111
(44.4%) were females, 71 (28.4%) were married or coha-
biting, 241 (96.4) were of Norwegian ethnicity, 74
(29.6%) had paid work, 60 (24.0%) were voluntarily
admitted and mean length of stay was 37.1 days. Partici-
pants were younger; more often had paid work, were
more often voluntarily admitted and were admitted for
longer lengths of stay than nonparticipants.
Degree of agreement between expert’s diagnoses and
clinicians’ diagnoses
The expert gave a mean of 3.4 diagnoses while the clini-
cians only gave 1.4. The most common diagnoses given
by the expert were drug and alcohol abuse (57%), major
depression without psychosis (49%) and anxiety disorder
(48%). Only major depression without psychosis was
common among the diagnoses made by clinicians (51%).
The agreement, as estimated by the kappa statistics,
between the expert and the clinicians ranges frompoor to good for the different diagnostic groups. Gen-
erally the agreement was better when comparing all
diagnoses given opposed to comparing only the first diag-
nosis given [12].
Especially concerning anxiety disorders (F40-41) the
agreement was poor (kappa = 0.12). While the expert
gave an anxiety disorder diagnosis to 122 patients, the
clinicians diagnosed anxiety disorder in only 15 of these,
and altogether in 17 patients. Very few patients were
assigned an anxiety disorder as their primary diagnosis,
only 3 by the expert and 2 by the clinicians. The
agreement was fair concerning substance use disor-
ders (F10-19) with a kappa value of 0.27. 144 patients
were diagnosed with substance use disorder by the expert,
and for four patients this was their primary diagnosis. The
corresponding figures regarding the clinicians were 45
and 22 patients respectively (Table 2).
Tables 3 shows the same results in some more detail
with regard to anxiety disorders (F40 – F41). Only 8
patients were given the same anxiety disorder diagnosis
by the clinicians as by the expert.
Concurrent comorbidity of both anxiety disorder (F40-41)
and substance use disorder (F10-19)
Seventy-six patients got both an anxiety disorder and a
substance use disorder diagnosis from the expert.
Seventy-five of these patients got additional diagnoses.
As the primary diagnosis 93% had an affective disorder
(F30-39) of which 26 (37%) were bipolar. One patient
had schizophrenia and 4 patients schizoaffective disorder
as the primary diagnosis. Only two of these patients
were diagnosed with concurrent anxiety and substance
use disorders by the clinicians (Table 4).
Discussion
This study casts doubt upon the validity of administra-
tive registers concerning comorbidity of anxiety and sub-
stance use disorder. To diagnose anxiety in particular,
seems to be neglected; the clinicians gave such a diagno-
sis to only 17% of those identified with an anxiety dis-
order (F40-41) by the expert. Concerning substance use
disorders (F10-19) the picture is somewhat better with
31% identified by the clinicians. Regarding concurrent
comorbidity of anxiety and substance use disorder, this
was to a very small degree identified by the clinicians;
only in two of 76 patients. Almost all these patients had
a primary affective disorder.
Not many studies have looked at the quality of admin-
istrative registers with regard to comorbidity. Only one
of the studies reviewed by Byrne et al. [11] did so, finding
that comorbidity was under-reported as in our study [21].
In an investigation of the Danish Psychiatric Register,
Hansen et al. [22] reported underdiagnosing of substance
use disorder by nearly 50%. Further, several studies
Table 2 Frequency and degree of agreement (Cohens
kappa/κ) between expert and clinician with regard to
substance use disorder and anxiety disorder; all
diagnoses set and primary diagnoses only (N=250)
All diagnoses Primary diagnoses
expert clin. expert clin.
Na nb nc nd κ Na nb nc nd κ




145 144 45 44 .27* 24 4 22 2 .20*
(57) (18) (2) (9)
Anxiety disorder
(F40-41)
124 122 17 15 .12* 4 3 2 1 .39*
(48) (7) (1) (1)
Na = number of patients given the diagnosis either by expert or by clinician.
nb = number of patients given the diagnosis by expert.
nc = number of patients given the diagnosis by a clinician.
nd = number of patients given the diagnosis by both expert and clinician.
* P<0.001.
Table 1 Characteristics and possible biases (Kruskal-Wallis & Chi-square (X2)) of the sample (N=250)
Excluded Included,no Participated X2/p
N = 197 participation
(N,%) N = 227 N =250
(N,%) (N,%)
Age 41.4 (sd 21.0) 44.2 ( sd 19.9) 40.4 (sd 15.2) Kruskal-Wallis, ns
Age groups > 39 yrs 122 (61.9%) 113 (49.8%) 139 (55.6%) X 2 = 26.64, p =.000
40 - 59 33 (16.8%) 64 (28.2%) 81 (32.4%)
60 + 42 (21.3%) 50 (22.0%) 33 (12.0%)
Females 92 (46.7% 97 (42.7%) 111 (44.4%) ns
Married 51 (26.2%) 48 (21.3%) 71 (28.4%) ns
Norwegian ethnicity 136 (69%) 215 (94.7%) 241 (96.4%) X2 = 92.34, p = .000
Employment/income Paid work 34 (17.3%) 50 (22.0%) 74 (29.6%)
National insurance benefits 121 (61.4%) 128 (56.4%) 116 (46.9%) X2 = 12.81, p = .012
Other 42 (21.3%) 49 21.6%) 60 (24.0%)
Voluntary admission 124 (63.6%) 138 (61.1%) 193 (78.8%) X2 = 19.89, p = .000
Length of first stay 11.6 (sd 19.6) 31.0 (sd 37.8) 37.1(sd 48.3) Kruskal Wallis p < .001
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nical practice [23,24].
The question is raised whether comorbidity actually is
an artefact of current diagnostic systems [25]. There is a
marked symptom overlap between at first hand affective
and anxiety disorders which could be a source of diag-
nostic unreliability and a dimensional classification sys-
tem based on shared features of anxiety and mood
disorders have been proposed [26]. In clinical practice a
dimensional approach to treatment is common and a
formal diagnosis is as a rule not given until discharge. It
could be that the clinicians are aware of comorbid an-
xiety and substance use without diagnosing it formally
[27]. One could imagine a kind of ethical considerations
of not stigmatizing the patient with too many diagnoses
giving only those who primarily brought the patient into
hospital. However, Zimmerman and Chelminski [24] re-
port underrecognition of anxiety disorders, for which
the patients want treatment, in psychiatric outpatients
with a principal diagnosis of major depression.
There could be several other reasons for this underdiag-
nosing of comorbidity. Treatment guidelines commonly
only relate to specific diagnostic groups like affective dis-
orders or anxiety disorders, and not to comorbid condi-
tions [28]. This could make the clinicians less aware of
comorbid conditions. The relation between co-occuring
substance and anxiety disorders has not received much at-
tention and is generally poorly understood. The diagnostic
challenge in relation to individuals with current substance
use disorders has been to devise diagnostic criteria and
measurement techniques that differentiate between intoxi-
cation and withdrawal symptoms and the symptoms of
psychiatric disorders. Many of the symptoms ofintoxication and withdrawal from alcohol and other sub-
stances resemble the symptoms of mood and anxiety dis-
orders [29]. Diagnostician using a structured interview
routinely asks control questions that delineates between
transient anxiety caused by substance withdrawal, and
chronic anxiety symptoms. The results could also be due
to the general phenomenon that clinicians rely on a limited
number of heuristic principles which in some instances
may lead to severe and systematic errors [30,31]. We be-
lieve clinicians are more apt to use a heuristic top-down ap-
proach when they diagnose patients, i. e. not asking about
other symptoms when the patient presents with depression.
The expert employing data from a structured clinical inter-
view, however, employs a bottom-up approach in the diag-
nostic process, i. e. asking questions which at first seem
Table 3 Anxiety disorder diagnoses (F40-41) set by the
clinicians (N=122)
Expert Clinicians
F40-41 The same diagnosis
as the expert
Agoraphobia F40.0 79 12 5
Social phobia F40.1 54 5 1
Specific phobias F40.2 24 4 0
Panic disorder F41.0 11 1 0
GAD F41.1 23 3 2
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higher using the top-down diagnostic approach and relying
on the diagnostic manual to confirm a clinical impression
rather than to openly screen for alternative or additional
diagnoses. Lack of relevant information in the patients’
records is shown to be a general phenomenon affecting all
diagnostic groups [32].
The importance of correctly diagnosing comorbidity in
clinical practice should be emphasized. Several studies
have shown that psychiatric comorbidity is associated
with a significantly increased probability of treatment
and that comorbidity can be regarded as an index of a
more severe course and outcome of mental disorders
[1]. Comorbidity is associated with more severe psychi-
atric symptoms, more functional disability, longer illness
duration, less social competence, and higher service
utilization [33]. Furthermore, patients with affective dis-
order and comorbid anxiety and substance abuse, show
less adherence to pharmacological treatment [34] and
need more specialized treatment [35]. It is shown that
such comorbidity is associated with suicidality in mood
disorders [36]. This underpins the importance of cor-
rectly diagnosing comorbid conditions in the clinic. The
psychiatric evaluation and diagnoses given at discharge
from psychiatric hospital will follow the patient and is
guiding for the treatment the patient will receive from
GP’s and psychiatric personnel in the community.
Concerning administrative consequences, not diagnos-
ing comorbidity represents an undercommunication of
the burden these patients represent to the health careTable 4 Concurrent comorbidity of anxiety (F40-41)






All patients 76 2 23 3
Affective disorder F30-39 70 (93%) 1 18 2
Bipolar disorder F31 26 (35%) 1 4 1
Sciz. spectrum F20(1) & F25(4) 5 (7%) 0 0 0system and consequently gives the wrong signals concern-
ing how to develop necessary services. Misleading
medical statistics may cause spurious comparisons
during the planning and evaluation of treatment for
patients [1]. Further, our findings suggest that register
diagnoses are dubious for research purposes when it
comes to comorbid psychiatric diagnoses. This is in
accordance with the investigations of Baca-Garcia
et al. [37,38] and McConville et al. [39].
Our study comprises only 250 patients, and only first
time admissions, so the generalizability of the findings
could be questioned. It could be argued that new
patients are more difficult to diagnose making the diag-
nostic validity of registers including all patients, better.
Compared with the studies reviewed by Byrne et al. [11]
on the diagnostic validity of administrative registers in
psychiatric research, our study has some advantages
strengthening the validity of the results. First, a struc-
tured diagnostic interview was performed, adding infor-
mation from the records when necessary, and the
clinical diagnoses were blind to the expert. On the other
hand, the expert never actually saw the patient. Thus the
observations, scorings and case notes could have been
evaluated otherwise if the expert had observed the
patient directly. The greatest possible caveat here is that
signs and symptoms may have been missed or misinter-
preted. However the expert only scored a symptom as
present if there was given a description of overt behav-
iour or citations from the patient in either the interview
protocol or in the hospital records. Furthermore there is
always a risk that diagnoses based on an interview which
screens for all psychiatric symptoms may be overinclusive.
This possible bias may result both from a “yes-saying”
response style of the patient, and from a tendency of the
interviewer to put weight on positive answers about signs
and symptoms that are not clinically significant. Thus,
there is a risk that the high number of diagnoses given by
the expert is a result of response bias and scoring bias.
However, we do not believe that this bias will disturb the
main findings. Structured interviews are shown to be bet-
ter than unstructured traditional diagnostic assessment
[40,41], and combining structured interviewing with a
review of the medical records appears to produce more
accurate primary diagnoses and to identify more se-
condary diagnoses than routine clinical methods or a
structured interview alone [42]. The studies reviewed
by Byrne et al. [11], where only case notes were checked
and no new information added, should be regarded more
as reliability studies than validity studies. Second, in our
study the clinicians’ diagnoses were blind to the expert
thus avoiding bias in either direction. A weakness in this
study may be that formal inter-rater reliability testing was
not done among the interviewers, however, there were
organized discussions among them, also on selected
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diagnoses are determined by researchers as found by
Cheniaux et al. [43]. However, to counter this, diagnoses
were not formulated by the interviewers, but by one
experienced researcher.
Conclusions
Even if the nosological status of the comorbidity concept
is by no means clear [25,44] the importance of correctly
diagnosing comorbidity should be emphasized and the
results from this study tells us that much work needs to
be done in the clinic in structuring the diagnostic
process, and in developing treatment guidelines for
comorbid conditions [41,45,46]. The validity of psychi-
atric administrative registers concerning comorbidity,
seems dubious for research purposes as well as for
administrative and clinical purposes.
In a previous paper we have reported that this is even
the case especially for bipolar disorder [12]. When it
comes to psychotic disorders such as substance use
induced psychosis and schizophrenia, the validity seems
satisfactory.
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